Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The DiGeorge syndrome-related protein pseudogene (ENSG00000224836) is a pseudogene, a nonfunctional DNA segment bearing sequence similarity to a functional gene, sometimes related by homology to genes in the DiGeorge syndrome (22q11.2 deletion syndrome) chromosomal region[2][4]. Pseudogenes do not produce functional proteins and are not considered drug targets, though their presence in the genome can sometimes complicate genetic studies due to sequence similarity with real genes[4]. There is no evidence that this pseudogene has any direct biological role, clinical significance, or relevance as a therapeutic target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DiGeorge syndrome-related protein pseudogene.